Filing Details
- Accession Number:
- 0000939767-19-000078
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-04-03 19:58:45
- Reporting Period:
- 2019-04-01
- Accepted Time:
- 2019-04-03 19:58:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 939767 | Exelixis Inc. | EXEL | Services-Commercial Physical & Biological Research (8731) | 043257395 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1312907 | M Alan Garber | C/O Exelixis, Inc. 1851 Harbor Bay Parkway Alameda CA 94502 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-04-01 | 15,000 | $5.92 | 76,329 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-04-01 | 15,000 | $24.00 | 61,329 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-04-01 | 15,000 | $4.57 | 76,329 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-04-01 | 15,000 | $23.97 | 61,329 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (right to buy) | Disposition | 2019-04-01 | 15,000 | $0.00 | 15,000 | $5.92 |
| Common Stock | Option (right to buy) | Disposition | 2019-04-01 | 15,000 | $0.00 | 15,000 | $4.57 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2010-05-19 | 2020-05-18 | No | 4 | S | Direct |
| 0 | 2012-05-24 | 2019-05-23 | No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2018 and modified on February 28, 2019.
- Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $23.89 to $24.14. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
- The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 19, 2010.
- The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 24, 2012.
Billionaire Hedge Funds
